Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
159,532,294
-
Share change
-
+9,553,906
-
Total reported value
-
$709,875,409
-
Put/Call ratio
-
114%
-
Price per share
-
$4.45
-
Number of holders
-
142
-
Value change
-
+$41,532,191
-
Number of buys
-
86
-
Number of sells
-
61
Institutional Holders of SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) as of Q2 2017
As of 30 Jun 2017,
SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
159,532,294 shares.
The largest 10 holders included
PAULSON & CO. INC., ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GREAT POINT PARTNERS LLC, CITADEL ADVISORS LLC, Tourbillon Capital Partners, L.P., MILLENNIUM MANAGEMENT LLC, and NORTHERN TRUST CORP.
This page lists
142
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.